Mark Smith is the founder of Finch Therapeutics. Latest round: IPO. Backed by Flagship Pioneering. Based in Somerville, MA.
Mark Smith is the Co-Founder and Chief Executive Officer of Finch Therapeutics, a clinical-stage biopharmaceutical company focused on developing microbiome therapies. He holds a PhD and leads the development of FIN-211, an investigational microbiome therapeutic for autism, among other indications.
Full founder directory · Investor directory · Company funding database · Fundraising library